ReviveMed

ReviveMed is a precision medicine company based in Cambridge, Massachusetts, founded in 2017. The company specializes in AI-enabled solutions that utilize metabolomics to predict disease outcomes, simulate patient responses, and optimize treatments in oncology, cardio-metabolic health, and liver diseases.

ReviveMed has developed a patented AI platform that creates metabolic twins—digital simulations of individual patient health and treatment responses. This innovative approach enhances outcomes across various diseases. The company focuses on data-driven insights to improve clinical trial designs, identify new therapeutic targets, and predict the benefits of immunotherapy for cancer patients. Their leadership team includes experts from MIT and the pharmaceutical industry, bringing a wealth of knowledge to their mission.